About US
Contact us
-
Reports: Pfizer to cut 180 jobs at two Irish plantsAfter Irish media reported 180 impending job cuts at Pfizer ($PFE) manufacturing plants in Cork, the company called employee meetings for tomorrow at both facilities for an official update. Local news2012/6/6
-
Roche's Zelboraf targeted by GSK melanoma drugsRoche ($RHHBY) may have to circle the wagons around its targeted melanoma drug Zelboraf. Positive data on two GlaxoSmithKline ($GSK) melanoma treatments have analysts predicting a quick assault on mar2012/6/5
-
ASCO: Data on J&J, Medivation meds spell trouble for ProvengeAfter last year's debut of Dendreon's ($DNDN)immunotherapy Provenge and Johnson & Johnson's ($JNJ)pill Zytiga, prostate cancer treatment may be in for another big shake-up. At the American Soci2012/6/5
-
New AstraZeneca chairman looks for CEOAstraZeneca($AZN) is on the hunt for a replacement for ex-CEO David Brennan.Leif Johansson, who takes over as chairman today, tells The Financial Times that finding the right leader is his first prior2012/6/4
-
SFDA releases 2011 Annual Report for National Adverse Drug Reaction MonitoringThe State Food and Drug Administration (SFDA) recently released the 2011 Annual Report for National Adverse Drug Reaction Monitoring, which gave information about national ADR reporting of 2011, inclu2012/6/4
-
Icahn plans another foray against Forest LabsForest Laboratories ($FRX) CEO Howard Solomon is having an unwelcome case of déjà vu. Activist investor Carl Icahn plans to come back to the proxy ring with another set of director nominees. Along2012/6/1
-
EMA database of adverse-event reports opens to publicThe European Medicines Agency has opened up access to reports of suspected drug side effects. The now-public database comprises reports on about 650 medications and active ingredients cleared for sale2012/6/1
-
SFDA Commissioner Yin Li meets the delegation of Ministry of Industry, Trade and Labor of IsraelOn May 29, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA) met with the delegation led by Mr. Shalom Simhon, Minister of Industry, Trade and Labor of Israel. Both sides exc2012/5/31
-
Adderall shortage spurs counterfeiters to step in, FDA saysDrug shortages are a conundrum for pharma. They're frustrating, even infuriating, to hospitals and patients. To counterfeiters, they're a promise of new business. For evidence, look no further than2012/5/31
-
Big Pharma sweats outcome of Supreme Court rulingAt 18% of gross domestic product, healthcare spending in the United States is the highest in the world. And if the healthcare reform bill gets shot down by the Supreme Court, pharma will pop into t2012/5/30